Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Golden Throat Holdings Group Co Current Ratio?
Golden Throat Holdings Group CoHKSE:06896 83 Current Ratio is 2.17 as of Dec. 2025, which is 14% below its 10-year median of 2.51. GuruFocus rates HKSE:06896 with a GF Score™ of 83/100 and a GF Value™ of HK$2.98 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 996 Drug Manufacturers companies, Golden Throat Holdings Group Co ranks better than 55.62% on this metric.
Golden Throat Holdings Group Co (HKSE:06896) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Golden Throat Holdings Group Co Current Ratio Related Terms
Golden Throat Holdings Group Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Golden Throat Holdings Group Co Current Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Golden Throat Holdings Group Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Golden Throat Holdings Group Co Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Golden Throat Holdings Group Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Golden Throat Holdings Group Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Golden Throat Holdings Group Co (HKSE:06896) has a Current Ratio of 2.17 as of Dec. 2025. This is 14% below median its historical median of 2.51. Over the past decade, Golden Throat Holdings Group Co's Current Ratio has ranged from 1.73 to 2.96. According to the industry distribution chart, Golden Throat Holdings Group Co ranks #442 out of 996 companies in the Drug Manufacturers industry, placing it in the top 44.4%.
Is Golden Throat Holdings Group Co's Current Ratio too high?
Golden Throat Holdings Group Co's current Current Ratio of 2.17 is 14% below median its 10-year median of 2.51. Over the past 10 years, this metric has ranged from a low of 1.73 to a high of 2.96. The Drug Manufacturers industry median Current Ratio is 1.92. Golden Throat Holdings Group Co's value of 2.17 is 13% above this industry median. Based on the distribution chart, Golden Throat Holdings Group Co ranks #442 out of 996 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Golden Throat Holdings Group Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Golden Throat Holdings Group Co's Current Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Golden Throat Holdings Group Co ranks #442 out of 996 companies for Current Ratio. This puts Golden Throat Holdings Group Co in the upper half of its industry. The industry median Current Ratio is 1.92. Golden Throat Holdings Group Co's value of 2.17 is 13% above this benchmark. Historically, Golden Throat Holdings Group Co's own Current Ratio has ranged from 1.73 to 2.96 over the past decade. While the company's 10-year median is 2.51 vs. the industry median of 1.92, Golden Throat Holdings Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 1.92, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Golden Throat Holdings Group Co's current Current Ratio of 2.17 is 13% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Golden Throat Holdings Group Co's current Current Ratio is 2.17, which is 14% below median its own 10-year median of 2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Golden Throat Holdings Group Co stock overvalued right now?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co (HKSE:06896) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$2.98, compared to a current price of HK$2.27 — trading 24% below its estimated fair value. The current Current Ratio is 2.17, which is 14% below median its 10-year median of 2.51 and 13% above the Drug Manufacturers industry median of 1.92. Golden Throat Holdings Group Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Golden Throat Holdings Group Co (HKSE:06896), the current Current Ratio is 2.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Golden Throat Holdings Group Co (HKSE:06896) Overvalued in 2026?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co stock appears to be undervalued.
The current stock price of HK$2.27 is trading 24% below its estimated GF Value™ of HK$2.98.
GuruFocus considers Golden Throat Holdings Group Co to be Modestly Undervalued.
Key valuation signals for HKSE:06896:
Current Ratio: 2.17 (14% below median its 10-year median of 2.51)
GF Value™: HK$2.98 vs. price of HK$2.27 (24% below fair value)
Industry Position: 13% above the Drug Manufacturers median (#442 of 996)
No single metric tells the full story. See the HKSE:06896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. The compqny manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives majority of its revenue from Mainland China.
83GF Score
Get the complete analysis for HKSE:06896
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06896 has been successfully added to your 
